Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS

NCT07095686 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: nL-CHCHD-001

Sponsor

n-Lorem Foundation

Collaborators

[object Object]